Scientists hunt for blood clues to decode rare brain cancer

NCT ID NCT07188077

Summary

This study aims to learn more about a rare type of brain cancer called primary central nervous system lymphoma (PCNSL). Researchers will analyze blood samples from 20 people, including patients with this brain lymphoma, patients with a similar lymphoma elsewhere in the body, and healthy volunteers. By comparing detailed chemical and immune system profiles, they hope to find patterns that could guide future research into better treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.